Dr. Sartor and Taylor discuss Copper-... - Advanced Prostate...

Advanced Prostate Cancer

22,367 members28,133 posts

Dr. Sartor and Taylor discuss Copper-67 (Cu-67 or 67Cu), the radioligand I am so curious about!

Maxone73 profile image
11 Replies

Dr Sartor interviews dr Taylor who is the lead researcher on copper isotopes to be used for precision medicine for prostate cancer and not only. The first patient with mCRPC treated with 2 infusions at therapeutic dose, complete remission...ok, luck, but still, I like it!

But their enthusiasm is higher than mine, I hope it's not marketing: "But prostate is our major area with bisPSMA. And that's Copper-67 bisPSMA. We're excited about that because of the early data, even in late-stage disease and having, you saw the complete response in the first patient we ever treated twice at what we thought was a therapeutic dose, was amazing. That wasn't a combination. That was after everything. And to have that sort of dramatic response."

urotoday.com/trials-in-prog...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
11 Replies
Samrecan profile image
Samrecan

Thanks for sharing - bolsters hope for us warrior brothers.

Maxone73 profile image
Maxone73 in reply toSamrecan

Thanks brother! My posts are mainly aimed towards that!

Mgtd profile image
Mgtd in reply toMaxone73

You amaze me with your research and thanks a million. How do we continue to follow this in the future.?

Maxone73 profile image
Maxone73 in reply toMgtd

I will post more! But you can simply enter the name of the trial of of the molecule in Google once in a while and filter the results by date

street-air profile image
street-air

Its somewhat annoying that the company behind this is located down the road from me in sydney but their trial for cu-67 going to 2026 is recruiting only in 5 american locations. was it so hard to add one Australian one?

clinicaltrials.gov/study/NC...

Aardvark4 profile image
Aardvark4 in reply tostreet-air

Perhaps the trial requirements are less restrictive in US than AU? Or get it passed in the largest global market first. There are many US approved/prescribed drugs and tests not available from the manufacturers elsewhere in the world.

Maxone73 profile image
Maxone73 in reply toAardvark4

Problem is that they often require you not only to cover the expenses of the trial but to rent an apartment for the whole duration of the monitoring and so on. You have to basically move to the USA for the length of the trial. I was even thinking about creating a sort of charity with home owners that would lend out some property at low price exclusively for people participating in trials. A kind of worldwide network….air b&t, bed & trial 😂

street-air profile image
street-air in reply toAardvark4

pet psma was pioneered in Australia first so it isnt like radio isotopes and pc are out of the wheelhouse here

Aardvark4 profile image
Aardvark4 in reply tostreet-air

population US 335 million AU 27 million, follow tne money. Would approval in AU open it up to access the US market; ask the FDA!

street-air profile image
street-air in reply toAardvark4

well it shouldn't be a binary choice can have one aussie arm

Bkraus1 profile image
Bkraus1

This sound very promising!! Thanks Maxone for the thread!! Does anyone know how to get a scan without going through a clinical trial? The phase 1 diagnostic trial is closed. If you have a negative PSMA scan wouldn’t it be worth it to try a cu based PSMA scan? It seems so many men have negative PSMA scans with rising PSA levels. I fully recognize that it is not FDA approved but a great opportunity exists!! Thanks to all in advance.

Not what you're looking for?

You may also like...

Clarity Update: Complete response in first patient ever treated with 2 doses of Cu-67 SAR-bisPSMA at 8GBq

Highlights A complete response, based on Response Evaluation Criteria In Solid Tumours (RECIST...
God_Loves_Me profile image

Have we discussed this new Australian Theranostic? Clarity’s CU-65/CU-67 bisPSMA. Maybe some of the smarter guys here may be up on it?

https://www.biospace.com/article/releases/first-patient-treated-in-clarity-s-cu-64-cu-67-sar-bispsma
Spyder54 profile image

Maybe because of "careful" patient selection, but still great: PSA Undetectable in First Patient Cu-67 SAR-bisPSMA

Positive results for mCRPC, very positive. Sorry if I have already posted this (my mind is not so...
Maxone73 profile image

Clarity Pharmaceuticals gains FDA fast-track status for advanced prostate cancer 64Cu-SAR-bisPSMA imaging -hopefully soon also for treatment

As you know by now, I am following this technology pretty closely as it is very promising and their...
Maxone73 profile image

copper chelation is not something from the past: phase 2 trial gives hope!

in heavily pre treated mCRPC Although the last participants in cohort 3 only completed dosing in...
Maxone73 profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.